Background:
Rapid viral evolution during untreated HIV-1 infection results in escape from autologous neutralizing antibodies (aNAbs). Escape often occurs within variable regions of the env gene, and at known epitopes of broadly neutralizing antibodies (bNAbs). Following ART initiation, viral evolution ceases, but aNAb activity persists against some viral variants in the latent reservoir. We hypothesized that identifying common escape mutations to aNAb will offer insight into the efficacy of passive and active immunization strategies.
Methods:
We have previously characterized neutralizing activity of aNAbs against autologous envelope pseudo-typed viral particles from individuals suppressed on ART. Neutralization data were matched with the corresponding env sequence, and a genetic signatures analysis (Bricault et al., CHM 2019) was performed to identify putative determinants of aNAb resistance. Single amino acid sites of interest were altered using site-directed mutagenesis (SDM) in sensitive envs to adopt the resistant genotype. Changes in neutralizing activity of aNAbs and bNAbs against altered envelope pseudoviruses were investigated.
Results:
Several amino acid sites were identified by bioinformatic analysis as having statistically significant association with aNAb resistance phenotype in a donor, 012. These single amino acid sites were altered by SDM in a sensitive env to reflect the resistant genotype. In this envelope sequence, a single alteration at the N332 glycan supersite- adding a glycan- significantly reduced the capacity of aNAb to neutralize the viral variant. Conversely, removal of the N332 glycan in a resistant envelope did not rescue neutralizing activity. Phenotypic changes were validated using the V3-glycan directed bNAb 10-1074, that is highly specific for the presence of a glycan at N332. Moreover, several other alterations did not impact aNAb neutralization capacity.
Conclusions:
These studies confirm the use of our experimental protocol to identify sites of aNAb and bNAb vulnerability within select envelope sequences. Only a single amino acid modification had the capacity to induce significant change in aNAb activity. This suggests that vulnerability to aNAb in latent reservoir viral variants could be the result of only a few instances of immune escape. Thus, immunization-based strategies for a cure may involve targeting a few key vulnerabilities in env.